Drug Updates

Hepatitis Reaction with Rituximab Sparks Drug Safety Alert

M.J. Burton, MD, K.L. Winthrop, MD, MSPH, & J.W. Baddley, MD, MPH | January 1, 2015

The FDA modifies rituximab prescribing information to stress risk of hepatitis B virus reactivation

Plus, rheumatology drug news, safety updates

Kurt Ullman | December 1, 2014

How vaccines, medications and rheumatic disease-related effects on immune system interact

How to manage the risks when prescribing medications for patients in chronic pain

Elena M. Massarotti, MD, & Peter H. Schur, MD | December 1, 2014

Rheumatology experts review history of LN, offer explanations for roadblocks to better therapies

Comfort Ability program provides psychological strategies to help children self-manage symptoms

Bruce Rothschild, MD | November 1, 2014

A reader questions whether insurers’ practice of promoting medications has undermined physicians’ ability to provide quality patient care

Plus, FX006, odanacatib and other rheumatology drug news, safety updates

Test measures efficacy of compounds for treating arthritis and their effect on glucose kinetics

Plus, rheumatology drug news, safety updates